av/celldex-therapeutics--big.svg

COM:CELLDEX

Celldex

  • Stock

USD

Last Close

26.22

22/11 21:00

Market Cap

2.41B

Beta: -

Volume Today

662.65K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
4.11M
-
3.59M
12.77%
5.48M
52.82%
6.79M
23.83%
12.74M
87.78%
9.54M
25.15%
3.57M
62.54%
7.42M
107.61%
4.65M
37.30%
2.36M
49.32%
6.88M
192.02%
cost of revenue
2.33M
-
3.01M
-
gross profit
1.78M
-
3.59M
101.80%
5.48M
52.82%
6.79M
23.83%
12.74M
87.78%
9.54M
25.15%
3.57M
62.54%
7.42M
107.61%
4.65M
37.30%
2.36M
49.32%
3.88M
64.40%
selling and marketing expenses
general and administrative expenses
14.80M
-
20.62M
39.29%
33.84M
64.08%
35.98M
6.33%
25.00M
30.51%
19.27M
22.93%
15.43M
19.94%
14.46M
6.29%
20.49M
41.73%
27.20M
32.74%
30.91M
13.68%
selling general and administrative expenses
14.80M
-
20.62M
39.29%
33.84M
64.08%
35.98M
6.33%
25.00M
30.51%
19.27M
22.93%
15.43M
19.94%
14.46M
6.29%
20.49M
41.73%
27.20M
32.74%
30.91M
13.68%
research and development expenses
67.40M
-
104.38M
54.87%
100.17M
4.03%
102.73M
2.55%
96.17M
6.38%
66.45M
30.91%
42.67M
35.78%
42.53M
0.32%
53.31M
25.34%
82.26M
54.30%
115.00M
39.81%
other expenses
1.01M
-
1.01M
0%
1.01M
0%
997K
1.58%
896K
10.13%
224K
75%
42.70M
18,964.73%
54.02M
26.48%
55.38M
2.52%
90.34M
63.14%
130.23M
44.16%
cost and expenses
85.55M
-
126.02M
47.30%
135.02M
7.15%
139.70M
3.47%
122.07M
12.62%
85.94M
29.60%
58.10M
32.40%
56.99M
1.91%
73.80M
29.49%
109.45M
48.31%
148.93M
36.06%
operating expenses
83.22M
-
126.02M
51.43%
135.02M
7.15%
139.70M
3.47%
122.07M
12.62%
85.94M
29.60%
58.10M
32.40%
56.99M
1.91%
73.80M
29.49%
109.45M
48.31%
145.92M
33.31%
interest expense
927K
-
15.97M
-
151.09M
845.97%
-2.91M
-
ebitda
-78.50M
-
-121.42M
54.68%
-130.87M
7.79%
-136.31M
4.15%
-96.03M
29.55%
-635K
99.34%
-58.17M
9,060.94%
-38.20M
34.34%
-67.56M
76.87%
-101.87M
50.78%
-139.03M
36.49%
operating income
-81.44M
-
-122.43M
50.33%
-129.54M
5.81%
-132.92M
2.61%
-121.53M
8.57%
-156.44M
28.73%
-55.03M
64.82%
-63.35M
15.12%
-71.24M
12.45%
-115.23M
61.75%
-142.04M
23.26%
depreciation and amortization
2.94M
-
1.01M
65.60%
1.01M
0%
997K
1.58%
5.31M
432.60%
224K
95.78%
-3.14M
1,502.23%
25.16M
900.92%
3.69M
85.35%
13.37M
262.74%
3.01M
77.50%
total other income expenses net
819K
-
4.35M
431.14%
2.34M
46.11%
4.39M
87.12%
-7.99M
282.08%
-75.55M
845.97%
4.15M
105.50%
2.41M
42.04%
505K
79.02%
2.91M
476.04%
613K
78.93%
income before tax
-81.55M
-
-118.08M
44.79%
-127.20M
7.72%
-128.53M
1.05%
-117.31M
8.73%
-151.95M
29.52%
-50.88M
66.52%
-60.95M
19.79%
-70.74M
16.06%
-112.33M
58.79%
-141.43M
25.91%
income tax expense
-819K
-
-4.35M
431.14%
-2.34M
46.11%
-8.77M
274.23%
-24.28M
176.81%
-765K
96.85%
-506K
33.86%
-1.17M
130.63%
-227K
80.55%
10.46M
4,707.05%
net income
-81.55M
-
-118.08M
44.79%
-127.20M
7.72%
-128.53M
1.05%
-93.03M
27.62%
-151.18M
62.51%
-50.37M
66.68%
-59.78M
18.68%
-70.51M
17.95%
-122.78M
74.13%
-141.43M
15.19%
weighted average shs out
5.32M
-
5.96M
12.06%
6.47M
8.56%
6.77M
4.61%
8.57M
26.61%
10.44M
21.84%
14.51M
38.93%
29.64M
104.32%
42.87M
44.64%
46.89M
9.37%
48.45M
3.33%
weighted average shs out dil
5.32M
-
5.96M
12.06%
6.47M
8.56%
6.77M
4.61%
8.57M
26.61%
10.44M
21.84%
14.51M
38.93%
29.64M
104.32%
42.87M
44.64%
46.89M
9.37%
48.45M
3.33%
eps
-15.33
-
-19.81
29.22%
-19.66
0.76%
-18.99
3.41%
-10.86
42.81%
-14.48
33.33%
-3.47
76.04%
-2.02
41.79%
-1.64
18.81%
-2.62
59.76%
-2.92
11.45%
epsdiluted
-15.33
-
-19.81
29.22%
-19.66
0.76%
-18.99
3.41%
-10.86
42.81%
-14.48
33.33%
-3.47
76.04%
-2.02
41.79%
-1.64
18.81%
-2.62
59.76%
-2.92
11.45%

All numbers in USD (except ratios and percentages)